These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9776715)

  • 41. Guanine polynucleotides are self-antigens for human natural autoantibodies and are significantly reduced in the human genome.
    Fattal I; Shental N; Ben-Dor S; Molad Y; Gabrielli A; Pokroy-Shapira E; Oren S; Livneh A; Langevitz P; Zandman-Goddard G; Sarig O; Margalit R; Gafter U; Domany E; Cohen IR
    Immunology; 2015 Nov; 146(3):401-10. PubMed ID: 26227667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human anti-DNA autoantibodies and induced antibodies against ROS-modified-DNA show similar antigenic binding characteristics.
    Alam K; Ali R
    Biochem Mol Biol Int; 1999 May; 47(5):881-90. PubMed ID: 10365260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peroxynitrite-modified DNA: a better antigen for systemic lupus erythematosus anti-DNA autoantibodies.
    Habib S; Moinuddin ; Ali R
    Biotechnol Appl Biochem; 2006 Feb; 43(Pt 2):65-70. PubMed ID: 16232128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lupus autoantibodies to native DNA preferentially bind DNA presented on PolIV.
    Kumar S; Bunting KA; Kalsi J; Hinks JA; Latchman DS; Pearl LH; Isenberg DA
    Immunology; 2005 Mar; 114(3):418-27. PubMed ID: 15720443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunological studies on peroxynitrite modified human DNA.
    Dixit K; Moinuddin ; Ali A
    Life Sci; 2005 Oct; 77(21):2626-42. PubMed ID: 16098994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: Elisa, dot blot and immunoblot].
    Ghedira I; Landolsi H; Mankai A; Fabien N; Jeddi M
    Pathol Biol (Paris); 2006 Apr; 54(3):148-54. PubMed ID: 16169158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
    Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
    Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoantibodies specific for alpha-enolase in systemic autoimmune disorders.
    Pratesi F; Moscato S; Sabbatini A; Chimenti D; Bombardieri S; Migliorini P
    J Rheumatol; 2000 Jan; 27(1):109-15. PubMed ID: 10648026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA sequence and conformation specificity of lupus autoantibodies. Preferential binding to the left-handed Z-DNA form of synthetic polynucleotides.
    Thomas TJ; Meryhew NL; Messner RP
    Arthritis Rheum; 1988 Mar; 31(3):367-77. PubMed ID: 3358800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodies.
    Herkel J; Mimran A; Erez N; Kam N; Lohse AW; Märker-Hermann E; Rotter V; Cohen IR
    J Autoimmun; 2001 Aug; 17(1):63-9. PubMed ID: 11488638
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus.
    Gussin HA; Ignat GP; Varga J; Teodorescu M
    Arthritis Rheum; 2001 Feb; 44(2):376-83. PubMed ID: 11229469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antigenic specificity of anti-ROS DNA antibodies: involvement of lysyl residues in antigen binding.
    Ara J; Ali R
    Biochem Mol Biol Int; 1995 Jan; 35(1):213-22. PubMed ID: 7537571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of nitric oxide modified DNA in the etiopathogenesis of systemic lupus erythematosus.
    Dixit K; Ali R
    Lupus; 2004; 13(2):95-100. PubMed ID: 14995001
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
    Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
    Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus.
    Gergely P; Pullmann R; Stancato C; Otvos L; Koncz A; Blazsek A; Poor G; Brown KE; Phillips PE; Perl A
    Clin Immunol; 2005 Aug; 116(2):124-34. PubMed ID: 15894513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.